Population Impact & Efficiency of Benefit‐Targeted Versus Risk-Targeted Statin Prescribing for Primary Prevention of Cardiovascular Disease [Epidemiology]

ConclusionsBenefit‐based targeting of statin therapy provides modest gains in efficiency over risk‐based prescribing and could theoretically help attain approximately half of the Healthy People 2020 impact goal with reasonable efficiency.

Source: JAHA:Journal of the American Heart Association - February 10, 2017 Category: Cardiology Authors: Pletcher, M. J., Pignone, M., Jarmul, J. A., Moran, A. E., Vittinghoff, E., Newman, T. Tags: Lipids and Cholesterol, Cardiovascular Disease, Epidemiology, Primary Prevention Original Research Source Type: research